Equatorial Guinea vs Hong Kong, China: Previously treated cases tested for RR-/MDR-TB
Equatorial Guinea
88.0%
in 2024
Hong Kong, China
87.0%
in 2024
Equatorial Guinea rank
90th
Hong Kong, China rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Equatorial Guinea
- Hong Kong, China
How they compare
Equatorial Guinea currently reports 88.0% against 87.0% in Hong Kong, China, a difference of 1.0%.
The two have swapped places 3 times across 12 shared years of data; in 2008 it was Hong Kong, China ahead.
Equatorial Guinea ranks 90th and Hong Kong, China ranks 92nd of 180 countries.
Hong Kong, China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Hong Kong, China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 55.0% | 55.0% | Hong Kong, China |
| 2010s | 48.6% | 64.8% | 16.2% | Hong Kong, China |
| 2020s | 60.6% | 87.8% | 27.2% | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Equatorial Guinea or Hong Kong, China?
- Equatorial Guinea, at 88.0% against 87.0% in Hong Kong, China as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Equatorial Guinea and Hong Kong, China?
- 1.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Hong Kong, China?
- 12 years are reported by both, from 2008 to 2024.
- How do Equatorial Guinea and Hong Kong, China rank globally for previously treated cases tested for rr-/mdr-tb?
- Equatorial Guinea ranks 90th and Hong Kong, China ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.